• / Free eNewsletters & Magazine
  • / My Account
Home>Research and Markets: Ovarian Cancer Drug Pipeline Update 2015: 257 companies plus partners developing 348 drugs targeting ovarian cancer in development

Research and Markets: Ovarian Cancer Drug Pipeline Update 2015: 257 companies plus partners developing 348 drugs targeting ovarian cancer in development

3party Content

Tue, 27 Jan 2015

Research and Markets: Ovarian Cancer Drug Pipeline Update 2015: 257 companies plus partners developing 348 drugs targeting ovarian cancer in development
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.